Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-048809

EVP, Chief Medical Officer gave up 1,860 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eisner Mark EVP, Chief Medical Officer 2023-09-06 Shares withheld for taxes −1,860 $0.96 $1,791 159,917 D
Loading xslF345X05/doc4.xml…